ESPR Esperion Therapeutics
- 2.080
- +0.020+0.97%
- 2.120
- +0.040+1.92%
Esperion Therapeutics News
Esperion to Report First Quarter 2024 Financial Results on May 7
Esperion (NASDAQ: ESPR) today announced it will report first quarter 2024 financial results before the market opens on Tuesday, May 7, 2024.
Applied Digital Reports Downbeat Results, Joins Nurix Therapeutics And Other Big Stocks Moving Lower In Friday's Pre-Market Session
U.S. stock futures were lower this morning, with the Dow futures falling over 50 points on Friday. Shares of Applied Digital Corporation (NASDAQ:APLD) fell sharply in today's pre-market trading after
Why Fastenal Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Shares of Fastenal Company (NASDAQ:FAST) fell sharply during Thursday's session following worse-than-expected first-quarter financial results. Fastenal reported first-quarter FY24 sales growth of 1.9
Express News | Esperion Therapeutics Shares Are Trading Lower. The Company Announced the Presentation of New Data From CLEAR Outcomes
Why Esperion Therapeutics Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket
Shares of Esperion Therapeutics, Inc. (NASDAQ:ESPR) shares rose sharply during today's pre-market trading after the company presented new data from CLEAR outcomes at ACC.24 highlighting value of NEX
Reported Sunday, Esperion Presents New Data From CLEAR Outcomes At ACCR 2024 Highlighting Value Of NEXLETOL Tablets In Diverse Populations
Patients With Obesity Who Took NEXLETOL Were 23% Less Likely to Experience a Major Adverse Cardiovascular Event (MACE-4) Compared to PlaceboNEXLETOL Demonstrated Clinical Benefit in Historically Under
Esperion Presents Important New Data From CLEAR Outcomes at ACC.24 Highlighting Value of NEXLETOL (Bempedoic Acid) Tablets in Diverse Populations Including Women, Hispanics/Latinx and Patients With Obesity
Esperion (Nasdaq: ESPR) today announced the presentation of results from three pre-specified subgroups from CLEAR Outcomes at the 2024 American College of Cardiology's Annual Scientific Sessions (ACC.24): women, Hispanic/Latinx, and patients with obesity.
Signet Jewelers, Dave & Buster's Entertainment, Blue Owl Capital And Other Big Stocks Moving Higher On Wednesday
U.S. stocks were higher, with the Dow Jones gaining over 50 points on Wednesday. Shares of Signet Jewelers Limited (NYSE:SIG) rose sharply during Wednesday's session after the company raised its FY25
Why Is Esperion Therapeutics (ESPR) Up 2% Since Last Earnings Report?
Esperion to Participate in 23rd Annual Needham Virtual Healthcare Conference
ANN ARBOR, Mich., March 26, 2024 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced its participation in the 23rd Annual Needham Virtual Healthcare Conference. Sheldon Koenig, President and
Express News | Esperion Announces Data From CLEAR Outcomes Sub-Groups as Poster Presentations, Moderated Session & Industry Expert Theatre To Be Presented At ACC.24
Esperion Announces Data From CLEAR Outcomes Sub-Groups as Poster Presentations, Moderated Session & Industry Expert Theatre to Be Presented at ACC.24
ANN ARBOR, Mich., March 25, 2024 (GLOBE NEWSWIRE) -- Esperion (NASDAQ:ESPR) today announced the acceptance of three CLEAR (Cholesterol Lowering via Bempedoic acid, an ACL-Inhibiting Regimen) Outcomes subgroup analyses
Esperion Therapeutics Price Target Maintained With a $16.00/Share by HC Wainwright & Co.
Esperion Therapeutics Price Target Maintained With a $16.00/Share by HC Wainwright & Co.
Esperion Stock Jumps 18% in Wake of FDA Label Expansions
Esperion Shares Continue Rise After Friday's FDA Approval for Nexlizet, Nexletol
By Chris Wack Esperion shares were up 16% to $2.67 after the company said Friday the U.S. Food and Drug Administration approved broad new label expansions for Nexletol bempedoic acid tablets and Nexl
Sector Update: Health Care Stocks Steady Premarket Monday
Health care stocks were steady premarket Monday as the iShares Biotechnology ETF (IBB) was inactive and the Health Care Select Sector SPDR Fund (XLV) was down a slight 0.1% recently. Masimo (MASI) act
12 Health Care Stocks Moving In Monday's Pre-Market Session
GainersLandos Biopharma (NASDAQ:LABP) shares moved upwards by 181.6% to $22.05 during Monday's pre-market session. The market value of their outstanding shares is at $68.7 million. As per the press re
Northland Securities Sticks to Their Hold Rating for Esperion (ESPR)
Market-Moving News for March 25th
MLGO: 102% | MicroAlgo Inc. Announced a Deep Clustering Algorithm Based on Multi-level Feature FusionMASI: 15% | Masmi shares are trading higher after the company announced it has authorized managemen
Top Premarket Gainers
MicroAlgo (MLGO) stock rose 52% in recent Monday premarket activity, recovering from moderate losses on Friday. Salarius Pharmaceuticals (SLRX) shares surged 24% after reporting Friday a narrower Q4 n
Analysis
Price Target
No Data
